Neuromuscular effects of succinylcholine following different pretreatments.
OBJECTIVE
To study the neuromuscular effects (onset, intensity, and duration of block) of succinylcholine following different pretreatments.


METHODS
Randomized open study.


METHODS
University-affiliated hospital.


METHODS
Fifty ASA physical status I and II adult inpatients undergoing elective ophthalmic surgery.


METHODS
Succinylcholine 0.5 mg/kg was administered after no pretreatment or after pretreatment with d-tubocurarine 0.05 mg/kg intravenously (IV) 3 minutes before, chlorpromazine 0.1 mg/kg i.v. 3 minutes before, alpha-tocopherol (vitamin E) 600 mg in three divided doses orally at 6-hour intervals, or aspirin 600 mg orally 1 hour before in groups of ten patients each.


RESULTS
Neuromuscular block by stimulation of the ulnar nerve at the wrist by application of train-of-four stimuli at 2 Hz every 12 seconds and recording the force of contraction of the adductor pollicis muscle. There was no significant difference in the time to occurrence of maximum block (49 to 53 seconds), reappearance of the twitch response (254 to 307 seconds), or complete recovery of twitch response (532 to 607 seconds) between the groups receiving no pretreatment and those pretreated with chlorpromazine, alpha-tocopherol, or aspirin. However, the time to maximum block (71 seconds) was significantly longer and the time to reappearance of the response (172 seconds) was significantly shorter (both p < 0.05) in the d-tubocurarine pretreated group in comparison with the control group. The time to complete recovery (420 seconds) also was shorter but not significantly different.


CONCLUSIONS
Of the pretreatments used, only d-tubocurarine interferes with the neuromuscular blocking effects of succinylcholine. Chlorpromazine, which attenuates the muscle pains as well as the increase in creatine kinase and can be administered with the same convenience, may be a better pretreatment in the prevention of side effects of succinylcholine.
McLoughlin
C C
CC
Department of Anaesthetics, Queen's University of Belfast, Northern Ireland.
Mirakhur
R K
RK
McCarthy
G J
GJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D000762:Anesthesia Recovery Period; D000771:Anesthesia, Intravenous; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology*; D002746:Chlorpromazine / Q000008:administration & dosage / Q000494:pharmacology*; D004347:Drug Interactions; D004558:Electric Stimulation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000503:physiopathology; D011229:Preanesthetic Medication; D013390:Succinylcholine / Q000008:administration & dosage / Q000494:pharmacology*; D014403:Tubocurarine / Q000008:administration & dosage / Q000494:pharmacology*; D014459:Ulnar Nerve; D014810:Vitamin E / Q000008:administration & dosage / Q000494:pharmacology*
D014810:Vitamin E; D013390:Succinylcholine; D001241:Aspirin; D002746:Chlorpromazine; D014403:Tubocurarine